EQS: latest releases

News releases provided by EQS Group AG EQS Group AG.

Polymetal: Analyst and Investor Day

Wednesday, October 14, 2020 - 7:01am

Polymetal will host its annual Analyst and Investor Day in the format of conference call and video webcast on Monday, 9 November 2020.

Key Points: 
  • Polymetal will host its annual Analyst and Investor Day in the format of conference call and video webcast on Monday, 9 November 2020.
  • During the call Vitaly Nesis, Group CEO, and Maxim Nazimok, CFO, will provide an update on Polymetal's key development projects.
  • The event will begin at 9:30 London time (12:30 Moscow time).
  • To join the call please dial:
    To participate from other countries, please dial any of the local access numbers listed above.

DGAP-News: Nordex Group wins orders for 1,229 megawatts in third quarter of 2020 with Delta4000 series accounting for 86 percent

Wednesday, October 14, 2020 - 7:01am

The Nordex Group has received orders for 271 wind turbine systems with a total output of 1,228.6 megawatts (MW) in the third quarter of 2020 (Q3 2019: 1,700.3 MW).

Key Points: 
  • The Nordex Group has received orders for 271 wind turbine systems with a total output of 1,228.6 megawatts (MW) in the third quarter of 2020 (Q3 2019: 1,700.3 MW).
  • The Delta4000-series turbines with an output range of four to five MW accounted for 86 percent of the orders.
  • In the third quarter, 31 percent of orders came from Europe, primarily from Germany, the Netherlands, the UK and France.
  • "The third quarter confirms that our customers in Europe, North America and Latin America are equally convinced by our highly efficient Delta4000 turbines.

2CRSi SA: OVHcloud teams up with 2CRSi for its Asian data centers.

Tuesday, October 13, 2020 - 6:03pm

With more than 1.5 million clients and already operating more than 30 data centers across 4 continents, OVHcloud is a global reference in the cloud market.

Key Points: 
  • With more than 1.5 million clients and already operating more than 30 data centers across 4 continents, OVHcloud is a global reference in the cloud market.
  • Thanks to 2CRSi's OCtoPus 3 servers, OVHcloud will benefit from the most cutting-edge technologies in the sector and recognised efficiency in terms of energy consumption.
  • The servers will be installed in OCtoRack 42 SL modular racks designed by 2CRSi to increase density of computing power per m while keeping adaptable dimensions in line with general data center standards.
  • "OVHcloud is the leading European cloud service provider and offers constantly expanding and increasingly specialised cloud solutions to sophisticated clients.

EQS-News: Medacta Launches M.U.S.T. 2.0 Instrumentation to Expand its Offerings for Spine Pathologies

Tuesday, October 13, 2020 - 6:03pm

2.0 instrumentation, a next generation solution for spine surgery designed to simplify the procedure and provide robust instruments in open surgery when treating degenerative spine pathologies.

Key Points: 
  • 2.0 instrumentation, a next generation solution for spine surgery designed to simplify the procedure and provide robust instruments in open surgery when treating degenerative spine pathologies.
  • instruments that incorporates an upgraded geometrical design to support every single step of the surgery.
  • 2.0 represents a further expansion of the fast-growing Medacta spine portfolio.
  • For more information on the Medacta spine surgery solutions, please visit spine.medacta.com

2CRSi SA: Revenue for the first half of 2020/21.

Tuesday, October 13, 2020 - 6:03pm

Note that the Group had reported pro forma 12-month revenue of 141.1m.

Key Points: 
  • Note that the Group had reported pro forma 12-month revenue of 141.1m.
  • Group business activity has been impacted on various levels by the world health crisis since the start of 2020.
  • Similarly, whereas the Group's first client accounted for 44% of total revenue in H1 2019, the share of revenue generated by the Group's first client came to just 13% in H1 2020/21.
  • The UK, from which Boston derived the majority of its revenue, is now the Group's biggest market, accounting for 44% of revenue.

SThree: Director/PDMR Shareholding

Tuesday, October 13, 2020 - 5:04pm

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.

Key Points: 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

DGAP-News: Themis Beteiligungs-Aktiengesellschaft announces partial sale of existing shares in Dermapharm Holding SE via Accelerated Bookbuilding

Tuesday, October 13, 2020 - 5:04pm

Themis Beteiligungs-Aktiengesellschaft, main shareholder in Dermapharm Holding SE, intends to place 5,384,000 shares in Dermapharm Holding SE (ISIN DE000A2GS5D8), corresponding to 10.0% of the outstanding share capital, by way of an Accelerated Bookbuilding, which is to commence immediately following the publication of this release, via Berenberg as Sole Global Coordinator and Sole Bookrunner.

Key Points: 
  • Themis Beteiligungs-Aktiengesellschaft, main shareholder in Dermapharm Holding SE, intends to place 5,384,000 shares in Dermapharm Holding SE (ISIN DE000A2GS5D8), corresponding to 10.0% of the outstanding share capital, by way of an Accelerated Bookbuilding, which is to commence immediately following the publication of this release, via Berenberg as Sole Global Coordinator and Sole Bookrunner.
  • The partial sale of shares is primarily aimed at increasing the free float and the trading volume in Dermapharm Holding SE.
  • Aside from Themis Beteiligungs-Aktiengesellschaft's announced sale of shares in Dermapharm Holding SE, Themis Beteiligungs-Aktiengesellschaft does currently not intend to further decrease its position as main shareholder in Dermapharm Holding SE.
  • Therefore, Themis Beteiligungs-Aktiengesellschaft committed to a 12 month lock-up following the envisaged placement.

DGAP-News: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds

Tuesday, October 13, 2020 - 4:12pm

The bonds will be convertible into new and/or existing no-par value ordinary bearer shares of MorphoSys.

Key Points: 
  • The bonds will be convertible into new and/or existing no-par value ordinary bearer shares of MorphoSys.
  • The convertible bonds with a denomination of EUR 100,000 each will be issued at 100% of their principal amount.
  • Unless previously converted, redeemed or repurchased and cancelled, the convertible bonds will be redeemed at their principal amount on October 16, 2025.
  • The convertible bonds were priced with a coupon of 0.625% per annum, payable semi-annually in arrear.

Edison Investment Research Limited: Edison issues initiation on Stern Groep (STRN)

Tuesday, October 13, 2020 - 4:12pm

Stern is trading at an FY21e P/E of 9.8x compared to the peer group average of 10.9x.

Key Points: 
  • Stern is trading at an FY21e P/E of 9.8x compared to the peer group average of 10.9x.
  • About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac.
  • The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise.At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders.
  • Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

DGAP-News: Secarna Pharmaceuticals and Denali Therapeutics enter into research and option agreement to develop novel antisense therapies in the field of neurodegenerative diseases

Tuesday, October 13, 2020 - 4:12pm

Under the terms of the agreement, Secarna will receive an undisclosed target-based technology access fee.

Key Points: 
  • Under the terms of the agreement, Secarna will receive an undisclosed target-based technology access fee.
  • Following the discovery and lead selection phase, Denali has a target-based option to in-license the respective development programs.
  • If Denali exercises an option, Secarna will receive an option exercise fee, as well as development and commercial milestone payments and tiered royalties.
  • "We are excited to collaborate with Denali to develop truly novel therapies for patients suffering from incurable neurodegenerative diseases.

 Sberbank makes changes to Executive Board

Tuesday, October 13, 2020 - 4:12pm

The Supervisory Board of Sberbank has decided to make changes to the Executive Board to improve the management model and implement strategic plans of Sber Group until 2023.

Key Points: 
  • The Supervisory Board of Sberbank has decided to make changes to the Executive Board to improve the management model and implement strategic plans of Sber Group until 2023.
  • The Executive Board will include the following members after obtaining the necessary approval from the Central Bank of the Russian Federation:
    -Kirill Tsaryov, Deputy Chairman of the Executive Board, Head of the Retail Business Unit
    - Sergey Maltsev, Deputy Chairman of the Executive Board, Head of Sales Network Unit
    - Natalya Alymova, member of the Executive Board, Head of Wealth Management Unit
    - Alexandra Buriko, member of the Executive Board, Head of Finances Unite.
  • Svetlana Kirsanova, Deputy Chairman of the Executive Board, Head of Retail Business, who decided to pursue other career opportunities outside Sber Group, and Oleg Ganeev, who is moving to the position of Senior Vice President responsible for large distressed assets, are leaving the Executive Board.
  • Herman Gref, CEO and Chairman of the Executive Board, Sberbank:
    "Each Sber leader, who will become a member of the Executive Board, has shown themselves to be a productive manager.

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Tuesday, October 13, 2020 - 3:08pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: TalkTalk Telecom Group plc

Tuesday, October 13, 2020 - 3:08pm

(b)Owner or controller of interests and short positions disclosed, if different from 1(a):

Key Points: 
  • (b)Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c)Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d)If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f)In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state "N/A"
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: William Hill plc

Tuesday, October 13, 2020 - 3:08pm

(b)Owner or controller of interests and short positions disclosed, if different from 1(a):

Key Points: 
  • (b)Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c)Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d)If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f)In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state "N/A"
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Tuesday, October 13, 2020 - 3:08pm

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.

Form 8.3 - The Vanguard Group, Inc.: G4S plc

Tuesday, October 13, 2020 - 3:08pm

(b)Owner or controller of interests and short positions disclosed, if different from 1(a):

Key Points: 
  • (b)Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c)Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d)If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f)In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state "N/A"
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc

Tuesday, October 13, 2020 - 3:08pm

(b)Owner or controller of interests and short positions disclosed, if different from 1(a):

Key Points: 
  • (b)Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c)Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d)If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f)In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state "N/A"
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

BrewBilt Manufacturing, Inc.: Beer, Beer and More Beer: BrewBilt Lands Europe and More Worth $50M Over 3 Years

Tuesday, October 13, 2020 - 1:12pm

Founded in 2014, the company began in a backyard shop by Jef Lewis with a vision of creating a profitable company in "Rural America".

Key Points: 
  • Founded in 2014, the company began in a backyard shop by Jef Lewis with a vision of creating a profitable company in "Rural America".
  • All BrewBilt products are designed and fabricated as "food grade" quality which enables the company to build vessels for food & beverage processing.
  • The forward-looking statements are based on management's expectations and are subject to a number of risks and uncertainties.
  • Management may elect to update forward-looking statements at some future point; however, it specifically disclaims any obligation to do so.

DGAP-News: Linde Announces Third Quarter 2020 Earnings and Conference Call Schedule

Tuesday, October 13, 2020 - 1:12pm

The company serves a variety of end markets including chemicals & refining, food & beverage, electronics, healthcare, manufacturing and primary metals.

Key Points: 
  • The company serves a variety of end markets including chemicals & refining, food & beverage, electronics, healthcare, manufacturing and primary metals.
  • Linde's industrial gases are used in countless applications, from life-saving oxygen for hospitals to high-purity & specialty gases for electronics manufacturing, hydrogen for clean fuels and much more.
  • Linde also delivers state-of-the-art gas processing solutions to support customer expansion, efficiency improvements and emissions reductions.
  • For more information about the company and its products and services, please visit www.linde.com.

DGAP-News: Mutares SE & Co. KGaA: Seventh Buyside Transaction in 2020: Mutares acquires the Engineering Services Business Line from Valmet Automotive Inc.

Tuesday, October 13, 2020 - 12:05pm

Mutares SE & Co. KGaA: Seventh Buyside Transaction in 2020: Mutares acquires the Engineering Services Business Line from Valmet Automotive Inc.

Key Points: 
  • Mutares SE & Co. KGaA: Seventh Buyside Transaction in 2020: Mutares acquires the Engineering Services Business Line from Valmet Automotive Inc.
  • Seventh Buyside Transaction in 2020: Mutares acquires the Engineering Services Business Line from Valmet Automotive Inc.
    - Acquired business with approx.
  • EUR 56 million in revenues in 2019
    Munich, 13 October 2020 - Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement on the acquisition of the Engineering Services Business Line from the Finnish automotive supplier Valmet Automotive Inc. (ISIN: FI4000074984).
  • Johannes Laumann, CIO of Mutares, comments: "We are excited to welcome the Engineering Services Business of Valmet Automotive in the Automotive & Mobility segment of our portfolio.

Hardman & Co Research: City of London Investment Group (CLIG): Boost from positive markets and deal completion

Tuesday, October 13, 2020 - 11:02am

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.

Key Points: 
  • About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
  • Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
  • Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
  • Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.

DGAP-News: Aspera License Management solution receives SAP netweaver(R) certification

Tuesday, October 13, 2020 - 10:01am

Being certified as powered by SAP NetWeaver(R) allows LicenseControl for SAP(R) to integrate more quickly into SAP environments and customers benefit from improved interoperability and supportability of the certified solution.

Key Points: 
  • Being certified as powered by SAP NetWeaver(R) allows LicenseControl for SAP(R) to integrate more quickly into SAP environments and customers benefit from improved interoperability and supportability of the certified solution.
  • While the product functionality is not certified by SAP, LicenseControl for SAP(R) recently earned the ITAM Review's SAP License Management Tools Certification .
  • The solutions' SAP license management features was independently verified through two onsite customer visits, which revealed that a significant ROI and ongoing savings were delivered.
  • "SAP customers running LicenseControl can confidently use the solution on the SAP platform, knowing that its SAP license management functionality has been independently verified," Myrja Schumacher said.

DGAP-News: Akarion and Hitachi Systems Security Working Together to Enhance Digital Trust

Tuesday, October 13, 2020 - 10:01am

Akarion and Hitachi Systems Security (HISYS-SEC) have reached a mutual agreement to bring their business vision, know-how and expertise together and work on promoting digital trust.

Key Points: 
  • Akarion and Hitachi Systems Security (HISYS-SEC) have reached a mutual agreement to bring their business vision, know-how and expertise together and work on promoting digital trust.
  • Specifically, Hitachi Systems Security and Akarion will work together to provide a holistic solution for managing organizational compliance that includes security, data protection, reliability and data ethics for corporate assets.
  • To this end, Hitachi Systems Security will offer its data protection and information security services to its international customers based on the Akarion Compliance Cloud.
  • Hitachi Systems Security was founded with one simple mission in mind - to make the internet a safer place for all.

DGAP-News: Wacker Chemie AG: WACKER Expands Capacity for Polymer Products at Nanjing

Tuesday, October 13, 2020 - 9:04am

Munich and Nanjing, October 13, 2020 - Wacker Chemie AG is expanding its Chinese polymer activities by investing around USD 100 million in building two new production plants at its Nanjing site.

Key Points: 
  • Munich and Nanjing, October 13, 2020 - Wacker Chemie AG is expanding its Chinese polymer activities by investing around USD 100 million in building two new production plants at its Nanjing site.
  • Our capacity expansion in Nanjing strengthens our position as the global leader for vinyl acetate-ethylene dispersions and polymer powders," notes Rudolf Staudigl, CEO of Wacker Chemie AG, as he explains the reasons for the investment.
  • At its fully integrated production site in the Nanjing Jiangbei New Material High-Tech Park, WACKER manufactures VAE dispersions, dispersible polymer powders and polyvinyl acetate solid resins.
  • WACKER does not plan to update its forward-looking statements, nor does it assume the obligation to do so.

DGAP-News: Apogenix Advances Clinical Development of CD95L Inhibitor Asunercept in European COVID-19 Phase II Trial

Tuesday, October 13, 2020 - 9:04am

Heidelberg, Germany, October 13, 2020 - Apogenix, a biopharmaceutical company developing next generation immunotherapeutics, announced today that the first patient has been enrolled in the ASUNCTIS trial.

Key Points: 
  • Heidelberg, Germany, October 13, 2020 - Apogenix, a biopharmaceutical company developing next generation immunotherapeutics, announced today that the first patient has been enrolled in the ASUNCTIS trial.
  • The ASUNCTIS trial is a multi-center, randomized, controlled, open-label phase II trial to assess the efficacy and safety of asunercept in patients with severe COVID-19 disease.
  • Checkpoint inhibitor asunercept, the company's lead immunotherapy candidate, is in late-stage clinical development with PRIME (PRIority MEdicines) designation by the European Medicines Agency for the treatment of glioblastoma.
  • Asunercept is exclusively licensed to CANbridge Life Sciences under a development and commercialization license covering China, Macao, Hong Kong, and Taiwan.

DGAP-News: Abivax secures EUR 15m non-dilutive financing from Kreos Capital

Tuesday, October 13, 2020 - 8:02am

This EUR 15m financing comprises two tranches of EUR 10m and EUR 5m respectively, with the first tranche to be fully drawn immediately, and a second tranche to be drawn before November 1, 2020.

Key Points: 
  • This EUR 15m financing comprises two tranches of EUR 10m and EUR 5m respectively, with the first tranche to be fully drawn immediately, and a second tranche to be drawn before November 1, 2020.
  • Didier Blondel, CFO of Abivax, said: "This non-dilutive EUR 15m loan from Kreos Capital, together with an additional EUR 5m loan option to be decided before the end of 2020, is an important step and in line with our plans to secure Abivax's funding.
  • The financing under the two first committed tranches amounts to a maximum of EUR 15m, composed of 15m straight bonds with a nominal value of EUR 1 each.
  • As part of the financing and subject to the common agreement of Abivax and Kreos, this EUR 15m financing could be supplemented by an additional tranche of up to EUR 5m under the same terms and conditions as described above.